Bone marrow cell cycle markers in inherited bone marrow failure syndromes
- PMID: 18606449
- PMCID: PMC2716700
- DOI: 10.1016/j.leukres.2008.05.020
Bone marrow cell cycle markers in inherited bone marrow failure syndromes
Abstract
Patients with inherited bone marrow failure syndromes (IBMFS) are at increased risk of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), possibly related to cell cycle dysregulation. In a cross-sectional analysis of bone marrow from 77 IBMFS, 71 sporadic conditions (AML, MDS, acquired aplastic anemia) and 22 normal controls we found overexpression of p53 in IBMFS, AML, and MDS; of Ki-67 in IBMFS and AML; and of survivin in IBMFS compared with all other groups. The patterns of expression of cell cycle markers in IBMFS are thus distinct. Longitudinal studies will determine the diagnostic and prognostic significance of these findings.
Figures
References
-
- Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D, editors. Nathan and Oski's Hematology of Infancy and Childhood 6th edition. WB Saunders; Philadelphia, PA: 2003. p. 280.
-
- Alter BP. Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure Syndromes. Hematology American Society of Hematology Education Program 2007. 2007. p. 29. - PubMed
-
- Alter BP. Bone marrow failure syndromes in children. Pediatr Clin N Amer. 2002;49:973–988. - PubMed
-
- Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol. 2007;8:275–283. - PubMed
-
- Fukuda S, Pelus LM. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood. 2001;98:2091–2100. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
